Table 1.
Antiviral and therapeutic mechanisms of AgNPs against different viruses.
Virus host |
Virus |
AgNP composition |
Mode of action |
Reference |
---|---|---|---|---|
Animal |
Human Immunodeficiency Virus |
Uncoated AgNP as well as PVP coated AgNP |
Impeding the gp120‐CD4 interaction during virus entry |
[11] |
Hepatitis B Virus |
Uncoated AgNP |
Inhibits virus replication |
[13] |
|
Hepatitis C Virus |
Green synthesized AgNPs from Amphimedon (Red Sea Sponge) |
Inhibits virus assembly through inactivation of NS3 Helicase and Protease |
[14] |
|
Influenza Virus |
Uncoated AgNP |
Reducing virus induced apoptosis and cytokine storm, gene delivery carriers of Influenza vaccines. |
[15] |
|
Respiratory Syncytial Virus |
PVP coated AgNP, uncoated AgNP |
Immunomodulating the immune profile of the host through the activation of neutrophils and anti‐inflammatory mediators |
[16] |
|
Polio Virus |
Electrochemically synthesized AgNP |
Mechanism unclear |
[17] |
|
Dengue Virus |
Mangrove‐fabricated AgNP |
Inhibits the expression of the envelope (E) gene and protein in dengue virus (serotype DEN‐2) |
[18] |
|
Chikungunya Virus |
Green synthesized AgNP from medicinal plants |
Mechanism unclear |
[19] |
|
Monkeypox Virus |
Uncoated as well as polysaccharide coated AgNP |
Mechanism unclear |
[20] |
|
Vaccinia Virus |
Uncoated AgNP |
Inhibiting macropinocytosis during virus entry |
[21] |
|
Tacaribe Virus |
Uncoated and polysaccharide coated AgNP |
Blocks virus replication |
[22] |
|
Rift Valley Fever Virus |
PVP coated AgNP |
Mechanism unclear |
[23] |
|
African Swine Fever Virus |
Uncoated AgNP |
Mechanism unclear |
[24] |
|
White Spot Syndrome Virus |
PVP coated AgNP |
Immunostimulation through the activation of PAMP recognition proteins |
[25] |
|
Enterovirus 71 |
PEI coated AgNP loaded with siRNA |
Inhibiting activation of caspase‐3, ROS and activation of Akt and p53 |
[26] |
|
Corona Virus |
Uncoated AgNP |
Mechanism unclear |
[27] |
|
Murine Norovirus and feline calcivirus |
AgNP‐decorated silica hybrid composites |
Synergistic interaction of silica and Ag nanocomposites to directly inactivate the viruses prior to their entry |
[28] |
|
Porcine reproductive and respiratory syndrome virus and porcine epidemic diarrhea virus |
Silver and Graphene Oxide nanocomposites |
Suppression of viral entry and stimulated Interferon‐α and Interferon Stimulated genes that are essential for activation of antiviral innate immune responses |
[29] |
|
|
Tobacco Mosaic Virus |
Biogenic AgNP prepared from the fermented broth ofPseudomonas fluorescens |
Mechanism unclear |
[30] |
Plant |
Bean Yellow Mosaic Virus |
AgNPs synthesized from extracellular agents produced by Bacillus licheniformis |
Mechanism unclear |
[31] |
Bacteriophage MS2 |
AgNP‐decorated silica hybrid composites |
Synergistic interaction of silica and Ag nanocompositesto directly inactivate the viruses prior to their entry |
[32] |
|
Bacteria |
Bacteriophage φX174 |
AgNP in conjunction with micrometer sized magnetic hybrid colloid |
Direct inactivation of viruses. Detailed mechanism unknown. |
[33] |
Bacteriophage UZ1 |
AgNP in conjunction withbacterial cell surface of Lactobacillus fermentumto form biogenic silver immobilized on microporous PVDF membranes |
Direct inactivation of viruses. Detailed mechanism unknown. |
[34] |